Skip to main content
Premium Trial:

Request an Annual Quote

Approaching Critical Mass?

Looks like people are already warming up for tomorrow's Open Access Day. In the Guardian, Richard Smith pens a column on Springer's acquisition of BioMed Central, which he says may turn out to be a pivotal moment in the history of scientific publishing. "I'm no seer, but it became obvious to me in the mid-90s, when ... I was the chief executive of the BMJ Publishing Group, that the transition to open access would have to happen," he writes. "Once all of science is open access – as it surely will be eventually – then the value of our scientific deposits may be greatly increased." He says that traditional publishers "subtract value by Balkanising the research."

In other open access events, Peter Suber reports that "Google and a group of publishers may be close to settling the publishers' lawsuit against the Google Library Project," the company's initiative of scanning books on library shelves and making them accessible online.

 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.